EMCDDA highlights new health risks as products and patterns of use change
31.05.2016
Europe’s drug market remains resilient, says the EU drugs agency (EMCDDA) today as it launches in Lisbon its European Drug Report 2016: Trends and Developments (1). In its annual review, the agency highlights: the health risks of high-potency products; the continued emergence of new substances;...
